BACKGROUND: Erythromycin is recommended for secondary prophylaxis in children with rheumatic heart disease, who are allergic to penicillin. CASE CHARACTERISTICS: A 9-year-old girl, with rheumatic heart disease, on secondary prophylaxis with erythromycin 250 mg BD, presented with acute rheumatic fever. OUTCOME: Responded to steroids and started on a higher dose (250 mg TDS) of erythromycin for secondary prophylaxis. MESSAGE: There is need to document the resistance of group A streptococci to erythromycin.